Roger Moody

Roger Moody has over 20 years of experience in the financial and healthcare industries. Roger is currently the Chief Financial Officer at Clinical Genomics, a position they have held since August 2017. Prior to that, they were the Board of Directors at GlySure Ltd from February 2015 to May 2020.

Moody began their career in 1989 as a finance manager at IBM. Roger then held various positions in corporate development and venture capital before becoming the Chief Operating Officer at Medsn, Inc. in May 2001. In May 2007, they became the Chief Financial Officer at Nanosphere, a position they held until February 2015. After a brief stint as a M&A advisor, Moody joined Clinical Genomics as their Chief Financial Officer in August 2017.

Roger Moody's educational career began at Bernards High School. Roger then went on to Syracuse University - Martin J. Whitman School of Management, where they earned their BS in finance. Finally, they earned their MBA from The University of Chicago Booth School of Business in finance and business economics.

They are on a team with Edward Rosen - Chief Strategy & Commercial Officer, Susanne K. Pedersen - VP, Science & Innovation & Co-founder, and Michele Houldsworth - VP, Regulatory Affairs. Their manager is Michael Paris, CEO.